Arginine deiminase mutant and methods of using the same
US-10557130-B2 · Feb 11, 2020 · US
US10815470B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10815470-B2 |
| Application number | US-201916718743-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 18, 2019 |
| Priority date | Mar 2, 2017 |
| Publication date | Oct 27, 2020 |
| Grant date | Oct 27, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An arginine deiminase mutant with improved enzyme activity and temperature stability and application thereof were provided, belonging to the technical field of genetic engineering and enzyme engineering. The arginine deiminase mutant is proline, namely Gly292 Pro, mutated from glycine near an enzyme active center. A wild-type arginine deiminase arcA coding gene is molecularly modified by a site-directed mutation technique to obtain a mutant enzyme ADIG292P, which has glycine at position 292 of an amino acid sequence of the wild type arginine deiminase mutated to proline. The arginine deiminase, modified by site-directed mutation, of the present invention has 1.5 times of increase in enzyme activity and 5.43 times of increase in half-life period at 40° C. compared with the wild-type enzyme, which solves the problems of low catalytic ability and temperature stability during the catalytic synthesis of citrulline using arginine deiminase, and lays a foundation for industrial production of efficient synthesis of citrulline and medication application.
Opening claim text (preview).
What is claimed is: 1. A gene encoding an arginine deaminase mutant, wherein the nucleotide sequence of the gene is set forth in SEQ ID NO: 2, and wherein the arginine deaminase mutant comprises mutation Gly292Pro compared to a parent arginine deiminase, greater enzyme activity and greater temperature stability than the parent arginine deiminase.
acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase · CPC title
Citrulline; Arginine; Ornithine · CPC title
specific for leukemia · CPC title
for bacteria · CPC title
acting on carbon to nitrogen bonds other than peptide bonds (3.5) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.